Danielle Gerhard, PhD | Mar 22, 2024 | 10+ min read
With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.
Researchers engineer a protease-mediated post-translational path faster than gene switches for processes that need to happen quickly, such as insulin release.
Scientists compared protein engineering with a synthetic library versus error-prone PCR to achieve better variant representation and simpler validation.
In this webinar, Gareth Rogers will discuss how mass photometry and automated mass photometry work using case studies that evaluated the oligomeric status of proteins.